PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Dry eyes (Hyetellose - Dry eyes)

Records returned : 22 (on 24 Nov 2024 at 16:20:29). .

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
11.08.01
Hyetellose
Dry eyes
Non Formulary
Formulations :
  • Eye drops (preservative free, unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
11.08.01
Carmellose sodium
Dry eyes
Green
Formulations :
  • Eye drops (preservative free)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild / moderate dry eye. Prescribe by brand (primary care)
1st line = Eyeaze Carmellose 0.5% PF or VIZcellose 0.5% PF 2nd line = Carmellose 0.5% PF or Ocu-Lube
11.08.01
Hypromellose
Dry eyes
Green
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild dry eye. Prescribe by brand (primary care) 1st line: Aapromel 0.3% or Aaculose 0.3% 2nd line: Lumecare 0.3%
11.08.01
Carbomer
Dry eyes
Green
Formulations :
  • Eye drops
  • Eye gel
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild / moderate dry eye. Prescribe by brand (primary care)
1st line: Aacomer 0.2% eye gel or Aacarb Carbomer 0.2% eye gel 2nd line: Clinitas carbomer 0.2% eye gel or Lumecare carbomer 0.2% eye gel
11.08.01
Carmellose sodium
Dry eyes
Green
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild / moderate dry eye. Prescribe by brand (primary care)
1st line = AaqEye carmellose 0.5% 2nd line = Lumecare Advance Carmellose 0.5%
Sodium hyaluronate
Dry eyes
Green
Formulations :
  • Eye drops
  • Eye drops (preservative free)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Moderate dry eye. Prescribe by brand (primary care)
1st line: Eyeaze preservative free (0.1%, 0.2%, 0.4%) VIZhyal preservative free (0.1%, 0.2%, 0.4%) 2nd line: Hy-Opti 0.2% Clinitas Multi preservative free (0.2%, 0.4%)
11.08.01
Hypromellose
Dry eyes
Green
Formulations :
  • Eye drops (preservative free)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild dry eye. Prescribe by brand (primary care) 1st line = Evolve Hypromellose preservative free 0.3% 2nd line = Hypromol preservative free 0.3%
11.08.01
Carbomer
Dry eyes
Green
Formulations :
  • Eye drops (preservative free)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild / moderate dry eye. Prescribe by brand (primary care)
1st line = Evolve Carbomer 980 prefervative free 0.2% eye gel 2nd line = Xailin 0.2% eye gel
11.08.01
Paraffin with lubricant
Dry eyes
Green
Formulations :
  • Eye ointment
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Moderate dry eye. Prescribe by brand: 1st line = HydraMed Night 2nd line = Moistueyes, Xailin Night, Hylo Night
11.08.01
Carbomer
Dry eyes
Green (see narrative)
Formulations :
  • Eye drops (unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild / moderate dry eye. Prescribe by brand (primary care)
Prescribe as Ocu-Lube Carbomer 0.2% Reserved for occasional use where unit dose is required (e.g. to carry in a bag)
11.08.01
Hypromellose
Dry eyes
Green (see narrative)
Formulations :
  • Eye drops (unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild dry eye. Prescribe by brand (primary care) as Lumecare Singles Hypromellose. Reserved for occasional use where unit dose is required (e.g. to carry in a bag)
11.08.01
Carmellose sodium
Dry eyes
Green (see narrative)
Formulations :
  • Eye drops (unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Mild / moderate dry eye. Prescribe by brand (primary care)
Prescribe as Lumecare Singles Carmellose. Reserved for occasional use where unit dose is required (e.g. to carry in a bag)
01.05.03
08.02.02
10.01.03
11.08.01
13.05.03
Ciclosporin
Dry eyes
Blue
Formulations :
  • Eye drops (unit dose)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
Important
0.1% ciclosporin (Ikervis). For dry eye disease that has not improved despite use of tear substitutes
Aeon Repair (sodium hyaluronate with carboxymethyl beta-glucan)
Dry eyes
Blue
Formulations :
  • Eye drops (preservative free)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Severe dry eye
Prescribe by brand.
Optive Fusion (sodium hyaluronate with carmellose sodium and glycerol)
Dry eyes
Blue
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Severe dry eye
Prescribe by brand.
Systane Balance (propylene glycol with polyethylene glycol)
Dry eyes
Blue
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Severe dry eye - patients with Meibomian glandular disease
Prescribe by brand.
Thealoz Duo (sodium hyaluronate with trehalose)
Dry eyes
Blue
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Severe dry eye
Prescribe by brand.
Serum eye drops
Dry eyes
Red
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
U
NHSE
Important
Specialist ophthalmology use only
11.08.01
Ciclosporin 0.05% Eye Drops
Dry eyes
Red
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
U
03.07.00
11.08.01
Acetylcysteine
Dry eyes
Red
Formulations :
  • Eye drops (preservative free)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
U
Important
5% and 10% preservative free (unlicensed) eye drops reserved for specialist use in severe dry eye
11.08.01
Paraffin soft yellow
Dry eyes
Non Formulary
Formulations :
  • Eye ointment
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
11.08.01
Polyvinyl alcohol
Dry eyes
Non Formulary
Formulations :
  • Eye drops
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More